Brewin Dolphin Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$136K Hold
1,820
0.01% 143
2022
Q1
$233K Hold
1,820
0.03% 121
2021
Q4
$244K Hold
1,820
0.03% 126
2021
Q3
$249K Hold
1,820
0.03% 124
2021
Q2
$194K Hold
1,820
0.02% 129
2021
Q1
$164K Hold
1,820
0.03% 121
2020
Q4
$168K Hold
1,820
0.03% 116
2020
Q3
$188K Sell
1,820
-264
-13% -$27.6K 0.03% 104
2020
Q2
$211K Buy
2,084
+1,820
+689% +$163K 0.05% 97
2020
Q1
$17.8K Buy
+264
New +$16.4K 0.01% 151

Other funds holding DXCM

Brewin Dolphin Wealth Management's DXCM Position: Q2 2022 in Review

Brewin Dolphin Wealth Management held its DexCom (DXCM) position steady in Q2 2022 at 1,820 shares worth $136K. The position accounts for 0.01% of the portfolio, ranked #143.

Brewin Dolphin Wealth Management first reported a position in DXCM in Q1 2020 and has held it in 10 quarters since. The position peaked at $249K in Q3 2021. 797 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

  • Brewin Dolphin Wealth Management held 1,820 shares of DexCom worth $136K as of Q2 2022.
  • Brewin Dolphin Wealth Management left its DexCom share count unchanged in Q2 2022.
  • DexCom made up 0.01% of Brewin Dolphin Wealth Management's portfolio in Q2 2022, its #143 holding.
  • Brewin Dolphin Wealth Management first reported a position in DexCom in Q1 2020 and has held it in 10 quarters since.
  • Brewin Dolphin Wealth Management's DexCom position peaked at $249K in Q3 2021.
  • 797 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2022, filed 14 Nov 2022.